20
Participants
Start Date
October 31, 2011
Primary Completion Date
August 31, 2015
Study Completion Date
January 31, 2016
Famitinib
Either at 12.5 mg, 16.5 mg、20 mg or 25 mg qd p.o., 2 weeks before concurrent chemoradiotherapy and D1-D49, exception D1, D22, and D43.
Cisplatin
100 mg/m2, D1, D22, and D43(q3w)
radiation（IMRT）
IMRT (Intensity-Modulated Radiation Therapy). Radiation is delivered to GTV at 70 Gy in 32-33 fractions, CTV1 at 60 Gy in 32-33 fractions and CTV2 at 54 Gy in 32-33 fractions
Department of Medical Oncology, Cancer Center, Sun Yet-sen University, Guangzhou
Sun Yat-sen University
OTHER
Jiangsu HengRui Medicine Co., Ltd.
INDUSTRY